$7.77
0.7711.00%
At close: -
$7.32
-0.45-5.79%
After Hours: Jan 17, 8:51 AM EDT
Ensysce Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Ensysce Biosciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $1.05 | $-4.35 | 124.1 % |
Q2 | 2024-08-14 | $-3.30 | $-5.85 | 43.6 % |
Q1 | 2024-05-13 | $-8.25 | $-13.95 | 40.9 % |
Q4 | 2024-03-15 | $-16.95 | $-13.05 | -29.9 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $3.42M | $250.00K | 1267.6 % |
Q2 | 2024-08-14 | $181.80K | $300.00K | -39.4 % |
Q1 | 2024-05-13 | $305.72K | $400.00K | -23.6 % |
Q4 | 2024-03-15 | $515.03K | $390.00K | 32.1 % |
Ensysce Biosciences (ENSC) is scheduled to report earnings on March 14, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $1.05, which beat the estimate of $-4.35.
The Actual Revenue was $3.4M, which beat the estimate of $250K.
Browse earnings estimates, EPS, and revenue on all stocks.